A citation-based method for searching scientific literature

D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude, H Sobol, M D Teare, J Struewing, A Arason, S Scherneck, J Peto, T R Rebbeck, P Tonin, S Neuhausen, R Barkardottir, J Eyfjord, H Lynch, B A Ponder, S A Gayther, M Zelada-Hedman. Am J Hum Genet 1998
Times Cited: 2144



Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
Times Cited: 1490




List of shared articles



Times cited


Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer.
Yaileen D Guzmán-Arocho, Shoshana M Rosenberg, Judy E Garber, Hilde Vardeh, Philip D Poorvu, Kathryn J Ruddy, Gregory Kirkner, Craig Snow, Rulla M Tamimi, Jeffrey Peppercorn,[...]. Br J Cancer 2022
1

Modification of BRCA1-associated breast cancer risk by HMMR overexpression.
Francesca Mateo, Zhengcheng He, Lin Mei, Gorka Ruiz de Garibay, Carmen Herranz, Nadia García, Amanda Lorentzian, Alexandra Baiges, Eline Blommaert, Antonio Gómez,[...]. Nat Commun 2022
0

Homologous recombination deficiency in breast cancer: Implications for risk, cancer development, and therapy.
Rayhaan M M Ali, Stuart A McIntosh, Kienan I Savage. Genes Chromosomes Cancer 2021
6

Decision aids for female BRCA mutation carriers: a scoping review protocol.
Sarah A McGarrigle, Geraldine Prizeman, Carol Spillane, Niamh Byrne, Amanda Drury, David Mockler, Elizabeth M Connolly, Anne-Marie Brady, Yvonne P Hanhauser. BMJ Open 2021
0

Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).
Carlo Saccardi, Stefania Zovato, Giulia Spagnol, Giulio Bonaldo, Matteo Marchetti, Lara Alessandrini, Silvia Tognazzo, Angela Guerriero, Amerigo Vitagliano, Antonio Simone Laganà,[...]. Gynecol Oncol 2021
2

Peutz-Jeghers Syndrome and the Role of Imaging: Pathophysiology, Diagnosis, and Associated Cancers.
Sergio Klimkowski, Mohamed Ibrahim, Juan J Ibarra Rovira, Mohamed Elshikh, Sanaz Javadi, Albert R Klekers, Abdelraham A Abusaif, Ahmed W Moawad, Kamran Ali, Khaled M Elsayes. Cancers (Basel) 2021
0

BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies.
Anbok Lee, Byung In Moon, Tae Hyun Kim. Ann Lab Med 2020
15

Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials.
Fengping Shao, Jun Liu, Yaoyun Duan, Li Li, Liqun Liu, Cai Zhang, Shanyang He. Biosci Rep 2020
9

Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer.
James Meehan, Mark Gray, Carlos Martínez-Pérez, Charlene Kay, Lisa Y Pang, Jennifer A Fraser, Amy V Poole, Ian H Kunkler, Simon P Langdon, David Argyle,[...]. Front Oncol 2020
16

Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer.
Mark Gray, James Meehan, Carlos Martínez-Pérez, Charlene Kay, Arran K Turnbull, Linda R Morrison, Lisa Y Pang, David Argyle. Front Oncol 2020
19



PRIMPOL-Mediated Adaptive Response Suppresses Replication Fork Reversal in BRCA-Deficient Cells.
Annabel Quinet, Stephanie Tirman, Jessica Jackson, Saša Šviković, Delphine Lemaçon, Denisse Carvajal-Maldonado, Daniel González-Acosta, Alexandre T Vessoni, Emily Cybulla, Matthew Wood,[...]. Mol Cell 2020
67

Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.
Cécile Le Page, Kurosh Rahimi, Manuel Rodrigues, Viola Heinzelmann-Schwarz, Neil Recio, Stefania Tommasi, Guillaume Bataillon, Lise Portelance, Lisa Golmard, Liliane Meunier,[...]. Gynecol Oncol 2020
9